Aplex Bio

Aplex Bio is at the forefront of advanced molecular testing delivering platform technologies that expand capabilities in precision genomics molecular diagnostics and high-frequency biological screening. Hyperplex PCR the companys next-generation platform introduces a new paradigm in molecular measurement by combining multiplexed detection molecular counting and single-nucleotide discrimination in a single workflow. The platform delivers digital-like single-copy sensitivity while scaling to 100 targets per well addressing limitations in plex precision and cost-efficiency that constrain both traditional PCR and sequencing technologies. Aplex Bio is dedicated to advancing the next generation of molecular diagnostics and enabling technologies for population-scale applications that can contribute to improved healthcare outcomes worldwide. The company is headquartered in Stockholm Sweden.